RA Capital Management Reduces Stake in VOR Biopharma

RA Capital Management, L.P., along with Peter Kolchinsky and Rajeev Shah, filed an amendment to their Schedule 13D, disclosing a reduction in their ownership of VOR Biopharma Inc. common stock. The filing indicates that RA Capital Management and its affiliates sold a significant number of shares, reducing their ownership from 31.3% to 20.9%. The transactions occurred between October 15, 2025, and October 20, 2025, with shares sold at weighted average prices ranging from $28.85 to $31.35. The filing also details the ownership structure, including warrants and stock options held by the reporting persons. This amendment is the seventh update to the original Schedule 13D filed on February 19, 2021.